Wednesday, November 12, 2025

Wednesday, November 12, 2025

Organization Directory

Refine Your Search Non-Profit Orgs Y

Type:

Filter by Org Category:

Filter By Name:


Trending

  1. 1 UROVANT SCIENCES: Announces U.S. FDA Approval of GEMTESA® (vibegron) 75 mg Tablets for the Treatment of Patients with Overactive Bladder (OAB)
  2. 2 GT BIOPHARMA: Announces FDA Data - GTB-3550 Trike™ Reduces Cancer Cells by 61.7% for a High-risk Myelodysplastic Syndromes (HR-MDS) Patient
FDA Health News